Navigation Links
Transcept Announces Plans to Reduce Expenses by Decreasing Staff Following Recent Completion of Purdue U.S. License and Collaboration Agreement
Date:8/18/2009

RICHMOND, Calif., Aug. 18 /PRNewswire-FirstCall/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT) today announced plans to reduce operating expenses by eliminating certain staff positions following its recently announced License and Collaboration Agreement with Purdue Pharmaceutical Products to commercialize Intermezzo((R) )(zolpidem tartrate sublingual tablet) in the United States.

Glenn A. Oclassen, President and Chief Executive Officer commented, "Our overall staffing needs have been modified by the development of Intermezzo((R)) to the point of NDA submission and our recently announced agreement with Purdue Pharmaceuticals to commercialize Intermezzo((R)) in the United States. Should Purdue elect to continue with our license and collaboration agreement after an FDA approval of Intermezzo((R)), Purdue will be responsible for the effort and costs associated with the commercialization of the product in the United States, including sales and marketing efforts in the primary care market, post-approval regulatory affairs activities and commitments, and product manufacturing. We are therefore phasing out certain positions that have been rendered non-essential by our development success to date and our agreement with Purdue. We believe that this important cost containment step is consistent with our long standing principle of conservative cash management."

Mr. Oclassen continued, "The streamlined team we will now have in place will be intently focused on seeking FDA approval for Intermezzo((R)), the worldwide commercialization of Intermezzo((R)), and the evaluation of potential additions to our product pipeline. The decision to make this approximately 30 percent reduction in our workforce was a difficult one for all of us and was ma
'/>"/>

SOURCE Transcept Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Transcept Pharmaceuticals Reports Second Quarter 2009 Financial Results
2. Transcept Pharmaceuticals to Report Second Quarter 2009 Results
3. Transcept Pharmaceuticals to Hold Conference Call on Agreement with Purdue Pharmaceutical Products L.P. to Commercialize Intermezzo(R) in the United States
4. Transcept Pharmaceuticals to Present at BMO Capital Markets Healthcare Conference on August 5, 2009
5. Transcept Pharmaceuticals Announces Expected FDA Extension of Regulatory Review Period for Intermezzo(R)
6. Transcept Pharmaceuticals to Present at Needham Life Sciences Conference on June 10, 2009
7. Transcept Pharmaceuticals Presents Data from Studies of Two Product Candidates at Annual Meeting of the American Psychiatric Association
8. Transcept Pharmaceuticals Reports First Quarter 2009 Financial Results
9. Transcept Pharmaceuticals Appoints Joseph T. Kennedy as General Counsel
10. Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results
11. Transcept Pharmaceuticals to Report Fourth Quarter 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... 30, 2014 USARAD Holdings ... teleradiology and specialty telemedicine solutions provider, including ... its existing teleradiology services at Mission Bend ER, ... expert telemedicine services, to the state-of-the-art, 24/7, freestanding ... result of this innovative partnership, there will be ...
(Date:10/30/2014)... 2014 The human brain is often ... exercised to help maintain better mental health, according to ... Express: Lose Your Memory in 100 Ways’ for just ... sometimes conflicting attitudes to help keep the reader constantly ... reader must decipher the hidden logic within. , “If ...
(Date:10/30/2014)... TX (PRWEB) October 30, 2014 ... released today its 2014 third quarter infection rates ... Texas boasted infection rates of only two percent ... patient satisfaction scores exceeding 98 percent. , “We ... quarter, which included rising satisfaction scores,” said Robert ...
(Date:10/30/2014)... 29, 2014 (HealthDay News) -- When it comes to heart ... men to delay care when they have symptoms that spell ... to the hospital with a more severe or advanced stage ... study author Catherine Kreatsoulas, a Fulbright Scholar and research fellow ... news release from the Heart and Stroke Foundation of Canada. ...
(Date:10/30/2014)... HealthDay Reporter WEDNESDAY, Oct. 29, ... during pregnancy may have effects on genital development in baby ... boys born to moms with greater exposure to a chemical ... the space between the genitals and anus. Anogenital distance is ... exposure to androgens ("male" hormones) during pregnancy. The researchers ...
Breaking Medicine News(10 mins):Health News:USARAD HOLDINGS INC, SECONDOPINIONS.COM® Pioneers Specialty On-Demand Telemedicine And Second Opinion Service At Houston-Based, Mission Bend Freestanding ER Chain 2Health News:USARAD HOLDINGS INC, SECONDOPINIONS.COM® Pioneers Specialty On-Demand Telemedicine And Second Opinion Service At Houston-Based, Mission Bend Freestanding ER Chain 3Health News:‘Dementia Express’ Offers Contradictory and Sometimes Reverse Thinking, All to Keep its Reader on Their Toes With an Active Mind. 2Health News:Victory Healthcare Releases Q3 Satisfaction, Infection Rates 2Health News:Victory Healthcare Releases Q3 Satisfaction, Infection Rates 3Health News:Women Often Ignore Signs of Heart Trouble 2Health News:Plastics' Chemical May Affect Baby Boys' Genital Development 2Health News:Plastics' Chemical May Affect Baby Boys' Genital Development 3
... Maharashtra have crashed the efforts of the state to become ... a polio-eradication drive have detected a 9-year old girl with ... affected by the P1 strain of the virus that is ... Chief Minister, Mr Vilasrao Deshmukh, and the Health Minister, Dr ...
... weight seems to have a connection, suggests a new ... to // indicate that babies who weigh less than ... down with Irritable Bowel Syndrome , in comparison to ... documented in the Journal "Gut". ,IBS is annoying, ...
... new study in the October issue of Radiology says ... osteoporotic fractures in women with 75 percent accuracy.// Researchers ... plan accordingly., ,"Approximately 45 percent of women have ... and their spine, leading to uncertainty as to how ...
... cells that may also explain how it evades the immune ... of Illinois at Chicago College of Medicine. ,The ... of Cell Biology. ,Both strains of the herpes ... the mouth, and HSV-2, genital herpes -- can infect the ...
... share vital information with the sincere motive of protecting ... The time is ripe to evolve a cohesive international ... necessitate the sharing of important information regarding influenza virus ... bird flu has taken flight and spread around the ...
... to the scientists from the University of Newcastle, UK, ... disease can eliminate the damage caused in cirrhosis of ... that fibrosis; the scarring linked with cirrhosis is irreversible, ... can be reversed by using Sulphasalazine.,Heavy drinking and obesity ...
Cached Medicine News:Health News:Formula Predicts Osteoporotic Fracture Risk 2Health News:Herpes Infects Cornea, Evades Immune Cells 2
(Date:10/30/2014)...  Misonix, Inc. (NASDAQ: MSON ), an ... markets innovative therapeutic ultrasonic instruments for spine surgery, neurosurgery ... report financial results for the first quarter fiscal year ... scheduled a conference call that same day, Thursday, November ... results. Interested parties can access the ...
(Date:10/30/2014)... WARSAW, Ind. , Oct. 30, 2014  Zimmer ... ZMH) today announced the future executive leadership team and ... of the Biomet transaction.  Zimmer also announced that the ... brands and will be named Zimmer Biomet, with the ... company following the closing of the merger.  The future ...
(Date:10/30/2014)... NEW YORK , Oct. 30, 2014  The ... United States is growing steadily, thanks to ... years, as a result of the economic downturn, retail ... was a year of opportunities, as the number of ... market researcher,s report, Retail Clinics Market Overview and ...
Breaking Medicine Technology:Misonix, Inc. To Report First Quarter Fiscal Year 2015 Financial Results On Thursday, November 6, 2014 2Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing 2Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing 3Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing 4Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing 5Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing 6Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing 7Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing 8Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing 9Report: Drugstore Chains Drive Retail Clinic Growth 2Report: Drugstore Chains Drive Retail Clinic Growth 3
... Calif., April 29, 2011 First Quarter ... by 321 institutions, up from 239 in Q4 2010 ... revenue Operational focus enables lower planned expense growth in ... by Astellas NGX-1998 Phase 2 clinical trial continues in ...
... Inovio Pharmaceuticals, Inc. (NYSE Amex: INO ), a ... cancers and infectious diseases, announced today that the company will ... Securities Research Conference San Francisco, CA, May 9-11, 2011 ... Dr. J. Joseph Kim, Ph.D., President & CEO May ...
Cached Medicine Technology:NeurogesX Reports First Quarter 2011 Results 2NeurogesX Reports First Quarter 2011 Results 3NeurogesX Reports First Quarter 2011 Results 4NeurogesX Reports First Quarter 2011 Results 5NeurogesX Reports First Quarter 2011 Results 6NeurogesX Reports First Quarter 2011 Results 7NeurogesX Reports First Quarter 2011 Results 8Inovio Pharmaceuticals to Present at Investor Conferences 2Inovio Pharmaceuticals to Present at Investor Conferences 3Inovio Pharmaceuticals to Present at Investor Conferences 4
The DSL-05-10-VZM Varicella Zoster IgM Enzyme-Linked Immunosorbent Assay (ELISA) kit provides materials for the determination of IgM-class antibodies to Varicella Zoster Virus in human serum. This as...
Inquire...
The CALBIOTECH, INC. (CBI), Mumps IgM ELISA tests system is an enzyme linked immunosorbent assay (ELISA) for the detection of IgM class antibodies to Mumps in human serum or plasma....
... is comprised of the TEG analyzer and the ... picture of the formation and dissolution of the ... two systems. ,Haemoscope's TEG analyzer is the only ... the reliable and proven model developed by Prof. ...
Medicine Products: